Expand SPRY Menu
SPRY MENU

SPRY Latest Press Releases

-- November 26, 2025 --

ARS Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference Globe Newswire 8:00 AM

-- November 10, 2025 --

ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy (epinephrine nasal spray) Globe Newswire 6:00 AM

-- November 4, 2025 --

ARS Pharma Launches Get neffy on Us for Patients with Severe Allergic Reactions to Improve Access to neffy (epinephrine nasal spray) Globe Newswire 8:00 AM

-- November 3, 2025 --

UPDATE -- ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting Globe Newswire 2:23 PM
ARS Pharmaceuticals Announces Conference Call and Webcast for its Third Quarter 2025 Financial Results Globe Newswire 8:00 AM
ARS Pharma to Present Real-World Data on Intranasal Epinephrine at 2025 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting Globe Newswire 7:45 AM

-- October 8, 2025 --

ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy (epinephrine nasal spray) Globe Newswire 8:00 AM

-- September 29, 2025 --

ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy Globe Newswire 4:05 PM

-- September 19, 2025 --

neffy (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis) Globe Newswire 8:00 AM

-- September 17, 2025 --

ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair Globe Newswire 9:00 AM

-- September 8, 2025 --

Real-World Evidence Supports Clinical Effectiveness of neffy (epinephrine nasal spray) in Patients Experiencing Anaphylaxis Globe Newswire 8:00 AM

-- August 31, 2025 --

Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion TipRanks 8:37 PM

-- August 28, 2025 --

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 13, 2025 --

ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy (epinephrine nasal spray) Globe Newswire 7:00 AM

-- August 4, 2025 --

ARS Pharmaceuticals Announces Conference Call and Webcast for its Second Quarter 2025 Financial Results Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes